Simvastin

DRUG2 trials

Sponsors

US Department of Veterans Affairs, IDIBAPS (Institut d' Investigacions Biomediques August Pi i Sunyer)

Conditions

Cirrose decompensated liver cirrhosis liver damage with loss of functionHypercholesterolemia

Phase 2

Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial.

Active, not recruitingNL-OMON45574

IDIBAPS (Institut d' Investigacions Biomediques August Pi i Sunyer)Cirrose decompensated liver cirrhosis liver damage with loss of function

Start: 2017-10-11Target: 5Updated: 2024-02-28

Unknown Phase

Systematic Management of High Cholesterol Utilizing Computer Monitoring

CompletedNCT00133094

US Department of Veterans AffairsHypercholesterolemia

Start: 2006-06-30End: 2007-12-31Target: 220Updated: 2015-04-07